Global Implantable Drug Delivery Devices Market

Implantable Drug Delivery Devices Comprehensive Study by Type (Biodegradable, Non-Biodegradable), Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others), Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Others), Technology (Diffusion, Osmotic, Magnetic, Other), Material (Silicon, Others) Players and Region - Global Market Outlook to 2027

Implantable Drug Delivery Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Implantable Drug Delivery Devices?
Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimize side-effects whilst increasing patient compliance. Implantable devices are called upon to serve a variety of functions, from vascular stents that preserve blood flow to electrostimulation devices that regulate heart rhythm or block spurious signals in the brain, to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. For over a decade there has been an increasing convergence between implantable devices and drug therapies, including devices that deliver drugs as a primary of action. This article reviews some representative applications that materials and processes device designers can leverage in developing new products for these growing markets.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBoston Scientific Corporation (United States), Abbott Laboratories (United States), Medtronic Plc. (Ireland), Merck & Co. (United States), Bausch & Lomb Inc. (Canada), Allergan, Inc. (Ireland), Bayer Healthcare (Germany), Alimera Sciences (United States), Eyepoint Pharmaceuticals (United States) and DSM Biomedical (United States)


The study covers a detailed analysis segmented by key business segments i.e. by type (Biodegradable and Non-Biodegradable) , by application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Implantable Drug Delivery Devices market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Implantable Drug Delivery Devices market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Boston Scientific Corporation (United States), Abbott Laboratories (United States), Medtronic Plc. (Ireland), Merck & Co. (United States), Bausch & Lomb Inc. (Canada), Allergan, Inc. (Ireland), Bayer Healthcare (Germany), Alimera Sciences (United States), Eyepoint Pharmaceuticals (United States) and DSM Biomedical (United States).

Market Overview:
On 8th February 2022, Second Sight Medical Products and Nano Precision Medical have agreed to merge to focus on drug-device medical implants. The two companies reached an agreement in which privately held Nano Precision Medical (NPM) will merge with a wholly-owned subsidiary of Second Sight in an all-stock transaction, with NPM surviving under Second Sight's ownership.
With the novelty and variety of IDDSs, it is impossible to apply a uniform regulation to all IDDS products. As a result, sponsors face regulatory challenges in registering and marketing their products. The FDA investigates pharmaceutical science literature and US Food and Drug Administration (US FDA) regulatory guidance to determine how any IDDS is classified, regulated, and introduced into the market. Any IDDS' regulatory classification as a drug, medical device, or combination product is the cornerstone in determining the regulatory pathway, which determines the quality control requirements before marketing approval. IDDSs are classified as combination products because they are made up of two or more regulated components (drugs, medical devices, or biological products) that are combined before use to function as a single entity.
The global Implantable Drug Delivery Devices market including many local as well as regional players. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings.

Implantable Drug Delivery Devices Market Dynamics:
AttributesDetails
Growth Drivers
  • Increasing Acceptance and Patient Compliance
  • Increasing Prevalence of Non-Communicable Diseases
Major Trends
  • Increasing Product Innovations and Approvals
Restraints
  • Product Recalls
Road Blocks / Challenges
  • High Cost of Treatment
Gaps & Opportunities
  • Improving Economic Conditions in the Region
  • Rising Geriatric Population, Technological Advancements, And Increasing Demand For Improved Implantable Drug Delivery Devices


Key highlights of the Global Implantable Drug Delivery Devices market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Implantable Drug Delivery Devices market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Implantable Drug Delivery Devices market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Implantable Drug Delivery Devices Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Implantable Drug Delivery Devices market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Implantable Drug Delivery Devices market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Implantable Drug Delivery Devices Manufacturer, Implantable Drug Delivery Devices Distributor & Suppliers, Emerging Companies, Original Equipment Manufacturer, Research and Development (R&D) Companies, Government and Independent Research Laboratories, Contract Research Organizations (CROs), Medical Research Laboratories, Academic Medical Institutes and Universities, Government Bodies, End-Users and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Biodegradable
  • Non-Biodegradable
By Application
  • Contraception
  • Ophthalmology
  • Cardiovascular
  • Diabetes
  • Oncology
  • Autoimmune Diseases
  • Others
By Product Type
  • Contraceptive Implants
  • Spinal Implants
  • Brachytherapy Seeds
  • Drug-Eluting Stents
  • Bio-absorbable Stents
  • Intraocular Stents
  • Infusion Pumps
  • Others

By Technology
  • Diffusion
  • Osmotic
  • Magnetic
  • Other

By Material
  • Silicon
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Acceptance and Patient Compliance
      • 3.2.2. Increasing Prevalence of Non-Communicable Diseases
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Treatment
    • 3.4. Market Trends
      • 3.4.1. Increasing Product Innovations and Approvals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Implantable Drug Delivery Devices, by Type, Application, Product Type, Technology, Material and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Implantable Drug Delivery Devices (Value)
      • 5.2.1. Global Implantable Drug Delivery Devices by: Type (Value)
        • 5.2.1.1. Biodegradable
        • 5.2.1.2. Non-Biodegradable
      • 5.2.2. Global Implantable Drug Delivery Devices by: Application (Value)
        • 5.2.2.1. Contraception
        • 5.2.2.2. Ophthalmology
        • 5.2.2.3. Cardiovascular
        • 5.2.2.4. Diabetes
        • 5.2.2.5. Oncology
        • 5.2.2.6. Autoimmune Diseases
        • 5.2.2.7. Others
      • 5.2.3. Global Implantable Drug Delivery Devices by: Type (Value)
        • 5.2.3.1. Biodegradable
        • 5.2.3.2. Non-Biodegradable
      • 5.2.4. Global Implantable Drug Delivery Devices by: Product Type (Value)
        • 5.2.4.1. Contraceptive Implants
        • 5.2.4.2. Spinal Implants
        • 5.2.4.3. Brachytherapy Seeds
        • 5.2.4.4. Drug-Eluting Stents
        • 5.2.4.5. Bio-absorbable Stents
        • 5.2.4.6. Intraocular Stents
        • 5.2.4.7. Infusion Pumps
        • 5.2.4.8. Others
      • 5.2.5. Global Implantable Drug Delivery Devices by: Technology (Value)
        • 5.2.5.1. Diffusion
        • 5.2.5.2. Osmotic
        • 5.2.5.3. Magnetic
        • 5.2.5.4. Other
      • 5.2.6. Global Implantable Drug Delivery Devices by: Material (Value)
        • 5.2.6.1. Silicon
        • 5.2.6.2. Others
      • 5.2.7. Global Implantable Drug Delivery Devices Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Australia
          • 5.2.7.2.6. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Implantable Drug Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic Plc. (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bausch & Lomb Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allergan, Inc. (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer Healthcare (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Alimera Sciences (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eyepoint Pharmaceuticals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DSM Biomedical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Implantable Drug Delivery Devices Sale, by Type, Application, Product Type, Technology, Material and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Implantable Drug Delivery Devices (Value)
      • 7.2.1. Global Implantable Drug Delivery Devices by: Type (Value)
        • 7.2.1.1. Biodegradable
        • 7.2.1.2. Non-Biodegradable
      • 7.2.2. Global Implantable Drug Delivery Devices by: Application (Value)
        • 7.2.2.1. Contraception
        • 7.2.2.2. Ophthalmology
        • 7.2.2.3. Cardiovascular
        • 7.2.2.4. Diabetes
        • 7.2.2.5. Oncology
        • 7.2.2.6. Autoimmune Diseases
        • 7.2.2.7. Others
      • 7.2.3. Global Implantable Drug Delivery Devices by: Type (Value)
        • 7.2.3.1. Biodegradable
        • 7.2.3.2. Non-Biodegradable
      • 7.2.4. Global Implantable Drug Delivery Devices by: Product Type (Value)
        • 7.2.4.1. Contraceptive Implants
        • 7.2.4.2. Spinal Implants
        • 7.2.4.3. Brachytherapy Seeds
        • 7.2.4.4. Drug-Eluting Stents
        • 7.2.4.5. Bio-absorbable Stents
        • 7.2.4.6. Intraocular Stents
        • 7.2.4.7. Infusion Pumps
        • 7.2.4.8. Others
      • 7.2.5. Global Implantable Drug Delivery Devices by: Technology (Value)
        • 7.2.5.1. Diffusion
        • 7.2.5.2. Osmotic
        • 7.2.5.3. Magnetic
        • 7.2.5.4. Other
      • 7.2.6. Global Implantable Drug Delivery Devices by: Material (Value)
        • 7.2.6.1. Silicon
        • 7.2.6.2. Others
      • 7.2.7. Global Implantable Drug Delivery Devices Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Australia
          • 7.2.7.2.6. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Implantable Drug Delivery Devices: by Type(USD Million)
  • Table 2. Implantable Drug Delivery Devices Biodegradable , by Region USD Million (2016-2021)
  • Table 3. Implantable Drug Delivery Devices Non-Biodegradable , by Region USD Million (2016-2021)
  • Table 4. Implantable Drug Delivery Devices: by Application(USD Million)
  • Table 5. Implantable Drug Delivery Devices Contraception , by Region USD Million (2016-2021)
  • Table 6. Implantable Drug Delivery Devices Ophthalmology , by Region USD Million (2016-2021)
  • Table 7. Implantable Drug Delivery Devices Cardiovascular , by Region USD Million (2016-2021)
  • Table 8. Implantable Drug Delivery Devices Diabetes , by Region USD Million (2016-2021)
  • Table 9. Implantable Drug Delivery Devices Oncology , by Region USD Million (2016-2021)
  • Table 10. Implantable Drug Delivery Devices Autoimmune Diseases , by Region USD Million (2016-2021)
  • Table 11. Implantable Drug Delivery Devices Others , by Region USD Million (2016-2021)
  • Table 12. Implantable Drug Delivery Devices: by Type(USD Million)
  • Table 13. Implantable Drug Delivery Devices Biodegradable , by Region USD Million (2016-2021)
  • Table 14. Implantable Drug Delivery Devices Non-Biodegradable , by Region USD Million (2016-2021)
  • Table 15. Implantable Drug Delivery Devices: by Product Type(USD Million)
  • Table 16. Implantable Drug Delivery Devices Contraceptive Implants , by Region USD Million (2016-2021)
  • Table 17. Implantable Drug Delivery Devices Spinal Implants , by Region USD Million (2016-2021)
  • Table 18. Implantable Drug Delivery Devices Brachytherapy Seeds , by Region USD Million (2016-2021)
  • Table 19. Implantable Drug Delivery Devices Drug-Eluting Stents , by Region USD Million (2016-2021)
  • Table 20. Implantable Drug Delivery Devices Bio-absorbable Stents , by Region USD Million (2016-2021)
  • Table 21. Implantable Drug Delivery Devices Intraocular Stents , by Region USD Million (2016-2021)
  • Table 22. Implantable Drug Delivery Devices Infusion Pumps , by Region USD Million (2016-2021)
  • Table 23. Implantable Drug Delivery Devices Others , by Region USD Million (2016-2021)
  • Table 24. Implantable Drug Delivery Devices: by Technology(USD Million)
  • Table 25. Implantable Drug Delivery Devices Diffusion , by Region USD Million (2016-2021)
  • Table 26. Implantable Drug Delivery Devices Osmotic , by Region USD Million (2016-2021)
  • Table 27. Implantable Drug Delivery Devices Magnetic , by Region USD Million (2016-2021)
  • Table 28. Implantable Drug Delivery Devices Other , by Region USD Million (2016-2021)
  • Table 29. Implantable Drug Delivery Devices: by Material(USD Million)
  • Table 30. Implantable Drug Delivery Devices Silicon , by Region USD Million (2016-2021)
  • Table 31. Implantable Drug Delivery Devices Others , by Region USD Million (2016-2021)
  • Table 32. South America Implantable Drug Delivery Devices, by Country USD Million (2016-2021)
  • Table 33. South America Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 34. South America Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 35. South America Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 36. South America Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 37. South America Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 38. Brazil Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 39. Brazil Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 40. Brazil Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 41. Brazil Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 42. Brazil Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 43. Argentina Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 44. Argentina Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 45. Argentina Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 46. Argentina Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 47. Argentina Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 48. Rest of South America Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 49. Rest of South America Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 50. Rest of South America Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 51. Rest of South America Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 52. Rest of South America Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 53. Asia Pacific Implantable Drug Delivery Devices, by Country USD Million (2016-2021)
  • Table 54. Asia Pacific Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 55. Asia Pacific Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 56. Asia Pacific Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 57. Asia Pacific Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 58. Asia Pacific Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 59. China Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 60. China Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 61. China Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 62. China Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 63. China Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 64. Japan Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 65. Japan Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 66. Japan Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 67. Japan Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 68. Japan Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 69. India Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 70. India Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 71. India Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 72. India Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 73. India Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 74. South Korea Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 75. South Korea Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 76. South Korea Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 77. South Korea Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 78. South Korea Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 79. Australia Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 80. Australia Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 81. Australia Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 82. Australia Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 83. Australia Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 85. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 86. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 87. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 88. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 89. Europe Implantable Drug Delivery Devices, by Country USD Million (2016-2021)
  • Table 90. Europe Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 91. Europe Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 92. Europe Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 93. Europe Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 94. Europe Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 95. Germany Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 96. Germany Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 97. Germany Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 98. Germany Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 99. Germany Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 100. France Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 101. France Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 102. France Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 103. France Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 104. France Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 105. Italy Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 106. Italy Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 107. Italy Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 108. Italy Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 109. Italy Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 110. United Kingdom Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 111. United Kingdom Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 112. United Kingdom Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 113. United Kingdom Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 114. United Kingdom Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 115. Netherlands Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 116. Netherlands Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 117. Netherlands Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 118. Netherlands Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 119. Netherlands Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 120. Rest of Europe Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 121. Rest of Europe Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 122. Rest of Europe Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 123. Rest of Europe Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 124. Rest of Europe Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 125. MEA Implantable Drug Delivery Devices, by Country USD Million (2016-2021)
  • Table 126. MEA Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 127. MEA Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 128. MEA Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 129. MEA Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 130. MEA Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 131. Middle East Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 132. Middle East Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 133. Middle East Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 134. Middle East Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 135. Middle East Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 136. Africa Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 137. Africa Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 138. Africa Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 139. Africa Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 140. Africa Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 141. North America Implantable Drug Delivery Devices, by Country USD Million (2016-2021)
  • Table 142. North America Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 143. North America Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 144. North America Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 145. North America Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 146. North America Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 147. United States Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 148. United States Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 149. United States Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 150. United States Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 151. United States Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 152. Canada Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 153. Canada Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 154. Canada Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 155. Canada Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 156. Canada Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 157. Mexico Implantable Drug Delivery Devices, by Type USD Million (2016-2021)
  • Table 158. Mexico Implantable Drug Delivery Devices, by Application USD Million (2016-2021)
  • Table 159. Mexico Implantable Drug Delivery Devices, by Product Type USD Million (2016-2021)
  • Table 160. Mexico Implantable Drug Delivery Devices, by Technology USD Million (2016-2021)
  • Table 161. Mexico Implantable Drug Delivery Devices, by Material USD Million (2016-2021)
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Implantable Drug Delivery Devices: by Type(USD Million)
  • Table 173. Implantable Drug Delivery Devices Biodegradable , by Region USD Million (2022-2027)
  • Table 174. Implantable Drug Delivery Devices Non-Biodegradable , by Region USD Million (2022-2027)
  • Table 175. Implantable Drug Delivery Devices: by Application(USD Million)
  • Table 176. Implantable Drug Delivery Devices Contraception , by Region USD Million (2022-2027)
  • Table 177. Implantable Drug Delivery Devices Ophthalmology , by Region USD Million (2022-2027)
  • Table 178. Implantable Drug Delivery Devices Cardiovascular , by Region USD Million (2022-2027)
  • Table 179. Implantable Drug Delivery Devices Diabetes , by Region USD Million (2022-2027)
  • Table 180. Implantable Drug Delivery Devices Oncology , by Region USD Million (2022-2027)
  • Table 181. Implantable Drug Delivery Devices Autoimmune Diseases , by Region USD Million (2022-2027)
  • Table 182. Implantable Drug Delivery Devices Others , by Region USD Million (2022-2027)
  • Table 183. Implantable Drug Delivery Devices: by Type(USD Million)
  • Table 184. Implantable Drug Delivery Devices Biodegradable , by Region USD Million (2022-2027)
  • Table 185. Implantable Drug Delivery Devices Non-Biodegradable , by Region USD Million (2022-2027)
  • Table 186. Implantable Drug Delivery Devices: by Product Type(USD Million)
  • Table 187. Implantable Drug Delivery Devices Contraceptive Implants , by Region USD Million (2022-2027)
  • Table 188. Implantable Drug Delivery Devices Spinal Implants , by Region USD Million (2022-2027)
  • Table 189. Implantable Drug Delivery Devices Brachytherapy Seeds , by Region USD Million (2022-2027)
  • Table 190. Implantable Drug Delivery Devices Drug-Eluting Stents , by Region USD Million (2022-2027)
  • Table 191. Implantable Drug Delivery Devices Bio-absorbable Stents , by Region USD Million (2022-2027)
  • Table 192. Implantable Drug Delivery Devices Intraocular Stents , by Region USD Million (2022-2027)
  • Table 193. Implantable Drug Delivery Devices Infusion Pumps , by Region USD Million (2022-2027)
  • Table 194. Implantable Drug Delivery Devices Others , by Region USD Million (2022-2027)
  • Table 195. Implantable Drug Delivery Devices: by Technology(USD Million)
  • Table 196. Implantable Drug Delivery Devices Diffusion , by Region USD Million (2022-2027)
  • Table 197. Implantable Drug Delivery Devices Osmotic , by Region USD Million (2022-2027)
  • Table 198. Implantable Drug Delivery Devices Magnetic , by Region USD Million (2022-2027)
  • Table 199. Implantable Drug Delivery Devices Other , by Region USD Million (2022-2027)
  • Table 200. Implantable Drug Delivery Devices: by Material(USD Million)
  • Table 201. Implantable Drug Delivery Devices Silicon , by Region USD Million (2022-2027)
  • Table 202. Implantable Drug Delivery Devices Others , by Region USD Million (2022-2027)
  • Table 203. South America Implantable Drug Delivery Devices, by Country USD Million (2022-2027)
  • Table 204. South America Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 205. South America Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 206. South America Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 207. South America Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 208. South America Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 209. Brazil Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 210. Brazil Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 211. Brazil Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 212. Brazil Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 213. Brazil Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 214. Argentina Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 215. Argentina Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 216. Argentina Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 217. Argentina Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 218. Argentina Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 219. Rest of South America Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 220. Rest of South America Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 221. Rest of South America Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 222. Rest of South America Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 223. Rest of South America Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 224. Asia Pacific Implantable Drug Delivery Devices, by Country USD Million (2022-2027)
  • Table 225. Asia Pacific Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 226. Asia Pacific Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 227. Asia Pacific Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 228. Asia Pacific Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 229. Asia Pacific Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 230. China Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 231. China Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 232. China Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 233. China Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 234. China Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 235. Japan Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 236. Japan Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 237. Japan Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 238. Japan Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 239. Japan Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 240. India Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 241. India Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 242. India Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 243. India Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 244. India Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 245. South Korea Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 246. South Korea Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 247. South Korea Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 248. South Korea Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 249. South Korea Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 250. Australia Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 251. Australia Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 252. Australia Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 253. Australia Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 254. Australia Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 255. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 256. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 257. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 258. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 259. Rest of Asia-Pacific Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 260. Europe Implantable Drug Delivery Devices, by Country USD Million (2022-2027)
  • Table 261. Europe Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 262. Europe Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 263. Europe Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 264. Europe Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 265. Europe Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 266. Germany Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 267. Germany Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 268. Germany Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 269. Germany Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 270. Germany Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 271. France Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 272. France Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 273. France Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 274. France Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 275. France Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 276. Italy Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 277. Italy Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 278. Italy Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 279. Italy Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 280. Italy Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 281. United Kingdom Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 282. United Kingdom Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 283. United Kingdom Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 284. United Kingdom Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 285. United Kingdom Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 286. Netherlands Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 287. Netherlands Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 288. Netherlands Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 289. Netherlands Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 290. Netherlands Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 291. Rest of Europe Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 292. Rest of Europe Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 293. Rest of Europe Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 294. Rest of Europe Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 295. Rest of Europe Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 296. MEA Implantable Drug Delivery Devices, by Country USD Million (2022-2027)
  • Table 297. MEA Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 298. MEA Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 299. MEA Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 300. MEA Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 301. MEA Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 302. Middle East Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 303. Middle East Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 304. Middle East Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 305. Middle East Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 306. Middle East Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 307. Africa Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 308. Africa Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 309. Africa Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 310. Africa Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 311. Africa Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 312. North America Implantable Drug Delivery Devices, by Country USD Million (2022-2027)
  • Table 313. North America Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 314. North America Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 315. North America Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 316. North America Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 317. North America Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 318. United States Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 319. United States Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 320. United States Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 321. United States Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 322. United States Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 323. Canada Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 324. Canada Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 325. Canada Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 326. Canada Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 327. Canada Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 328. Mexico Implantable Drug Delivery Devices, by Type USD Million (2022-2027)
  • Table 329. Mexico Implantable Drug Delivery Devices, by Application USD Million (2022-2027)
  • Table 330. Mexico Implantable Drug Delivery Devices, by Product Type USD Million (2022-2027)
  • Table 331. Mexico Implantable Drug Delivery Devices, by Technology USD Million (2022-2027)
  • Table 332. Mexico Implantable Drug Delivery Devices, by Material USD Million (2022-2027)
  • Table 333. Research Programs/Design for This Report
  • Table 334. Key Data Information from Secondary Sources
  • Table 335. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Implantable Drug Delivery Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Implantable Drug Delivery Devices: by Application USD Million (2016-2021)
  • Figure 6. Global Implantable Drug Delivery Devices: by Type USD Million (2016-2021)
  • Figure 7. Global Implantable Drug Delivery Devices: by Product Type USD Million (2016-2021)
  • Figure 8. Global Implantable Drug Delivery Devices: by Technology USD Million (2016-2021)
  • Figure 9. Global Implantable Drug Delivery Devices: by Material USD Million (2016-2021)
  • Figure 10. South America Implantable Drug Delivery Devices Share (%), by Country
  • Figure 11. Asia Pacific Implantable Drug Delivery Devices Share (%), by Country
  • Figure 12. Europe Implantable Drug Delivery Devices Share (%), by Country
  • Figure 13. MEA Implantable Drug Delivery Devices Share (%), by Country
  • Figure 14. North America Implantable Drug Delivery Devices Share (%), by Country
  • Figure 15. Global Implantable Drug Delivery Devices share by Players 2021 (%)
  • Figure 16. Global Implantable Drug Delivery Devices share by Players (Top 3) 2021(%)
  • Figure 17. Global Implantable Drug Delivery Devices share by Players (Top 5) 2021(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 21. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 23. Medtronic Plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 24. Medtronic Plc. (Ireland) Revenue: by Geography 2021
  • Figure 25. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 27. Bausch & Lomb Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 28. Bausch & Lomb Inc. (Canada) Revenue: by Geography 2021
  • Figure 29. Allergan, Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Allergan, Inc. (Ireland) Revenue: by Geography 2021
  • Figure 31. Bayer Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Bayer Healthcare (Germany) Revenue: by Geography 2021
  • Figure 33. Alimera Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 34. Alimera Sciences (United States) Revenue: by Geography 2021
  • Figure 35. Eyepoint Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 36. Eyepoint Pharmaceuticals (United States) Revenue: by Geography 2021
  • Figure 37. DSM Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 38. DSM Biomedical (United States) Revenue: by Geography 2021
  • Figure 39. Global Implantable Drug Delivery Devices: by Type USD Million (2022-2027)
  • Figure 40. Global Implantable Drug Delivery Devices: by Application USD Million (2022-2027)
  • Figure 41. Global Implantable Drug Delivery Devices: by Type USD Million (2022-2027)
  • Figure 42. Global Implantable Drug Delivery Devices: by Product Type USD Million (2022-2027)
  • Figure 43. Global Implantable Drug Delivery Devices: by Technology USD Million (2022-2027)
  • Figure 44. Global Implantable Drug Delivery Devices: by Material USD Million (2022-2027)
  • Figure 45. South America Implantable Drug Delivery Devices Share (%), by Country
  • Figure 46. Asia Pacific Implantable Drug Delivery Devices Share (%), by Country
  • Figure 47. Europe Implantable Drug Delivery Devices Share (%), by Country
  • Figure 48. MEA Implantable Drug Delivery Devices Share (%), by Country
  • Figure 49. North America Implantable Drug Delivery Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corporation (United States)
  • Abbott Laboratories (United States)
  • Medtronic Plc. (Ireland)
  • Merck & Co. (United States)
  • Bausch & Lomb Inc. (Canada)
  • Allergan, Inc. (Ireland)
  • Bayer Healthcare (Germany)
  • Alimera Sciences (United States)
  • Eyepoint Pharmaceuticals (United States)
  • DSM Biomedical (United States)
Additional players considered in the study are as follows:
Delpor Inc. (United States) , Teleflex Incorporated (United States) , 3M Company (United States) , Others
Select User Access Type

Key Highlights of Report


Aug 2022 236 Pages 72 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Implantable Drug Delivery Devices Market Quantitative research analysis
Global Implantable Drug Delivery Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Implantable Drug Delivery Devices Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Implantable Drug Delivery Devices market is dominated by United States Players and may generate healthy valuation by 2027.
  • Increasing Acceptance and Patient Compliance
  • Increasing Prevalence of Non-Communicable Diseases
dominated the Implantable Drug Delivery Devices market. This is attributable to growing trend of "Increasing Product Innovations and Approvals"

Know More About Global Implantable Drug Delivery Devices Market Report?

Have a Query? Click Here

Other Related Reports

Central Fill Pharmacy Automation System Comprehensive Study by Application (Inpatient Pharmacy, Outpatient Pharmacy, Retail Pharmacy, Others), Services (Consulting, Workflow and process optimization,...
$ 3500
Kyphoplasty Comprehensive Study by Type (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems, Instruments), Application (Vertebral Alignment Restor...
$ 3800
Salt Rooms Construction Comprehensive Study by Type (Salt Walls, Bricks & Tiles, Salt Booths & Capsules, Salt Beds & Tables, Halogenerator, Salt Binder, Salt Lamp, Others), Application (Spa and Welln...
$ 3800
Pet Animal Health Product Comprehensive Study by Type (Vaccines, Pharmaceuticals, Calcium Supplement, Others), End Users (Commercials, Household, Pet hospital, Others), Distribution Channels (Online,...
$ 3800
Papillomavirus Hpv Testing Comprehensive Study by Type (HPV Testing, Pap Test), Application (Cervical Cancer Screening, Vaginal Cancer Screening, Molecular Diagnostics, Research Use), End User (Labo...
$ 3800
Paediatric Epilepsy Therapeutics Comprehensive Study by Application (Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers), Disease Type (Benign Rolandic Epilepsy, Childhood ...
$ 3800